The rising frequency of Parkinson's disease and epilepsy is predicted to drive up demand for DBS devices. Major market players are focusing on the approval and introduction of new DBS devices to extend their product portfolio, and key market players are focusing on the market launch of updated versions of their previously authorised DBS devices, which is projected to promote market growth. One of the major reasons impeding the growth of the global deep brain stimulation device market is the related hazards connected with deep brain stimulation operations such as lead misplacement and brain haemorrhage. The implanted pulse generator, for example, is the primary power source and programmable component of DBS devices (IPG). The use of deep brain stimulation devices for Parkinson's disease is expected to be limited because to the risk of infection caused by IPG. As a result, healthcare stakeholders should educate patients on the usage of tack-up sutures and low-profile devices, as well as antimicrobial impregnation and co-administration.
According to Coherent Market Insights, Global Deep Brain Stimulation Device Market size was valued at US$ 1,188.9 million in 2022 and is expected to witness a CAGR of 9.8% over the forecast period (2022 – 2030).
Key Leaders in the Deep Brain Stimualtion Industry:
1. Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
2. Medtronic, Inc.
Medtronic Navigation, Inc. provides integrated navigation and intra-operative imaging solutions. The company was founded in 1995, headquartered in Colorado, U.S.
3. St. Jude Medical
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn., St. Jude Medical. The company was founded in 1979. The company is acquired by Abott.
4. Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
5. Cyberonics, Inc.
Cybersonics, Inc. designs and develops ultrasonic products. The Company provides finite element analysis, circuit board layout, and custom software products. Cybersonics is based in the State of Pennsylvania. The company was founded in 1995.
6. Neuronetics
Neuronetics, Inc., a commercial stage medical Technology Company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
7. Aleva Neurotherapeutics SA
Aleva Neurotherapeutics develops the next generations of implantable Deep Brain Stimulation systems, based on a MEMS technology. Aleva has been was founded in 2008 in Lausanne, Switzerland. It has raised 42 MUSD to date from prominent VCs, private investors and a strategic investor. The company is ISO13485 certified. On 14 September 2022, Aleva Neurotherapeutics SA, announced the CE approval of its MRI labeling for the directSTIM™ DBS System, to be used in a full-body magnetic resonance imaging (MRI) environment.
*Definition-The deep brain stimulation (DBS) device, also known as a brain pacemaker, assists in the relief of Parkinson's disease symptoms (PD). Although DBS is the most recommended choice, there are other surgical procedures such as Thalamotomy and Pallidotomy that do not entail tissue damage and are reversible.
